![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 8, 5728-5735, February 21, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The receptor protein-tyrosine phosphatase (PTP)
DEP-1 (CD148/PTP-
Hepatocyte Growth Factor Receptor Tyrosine Kinase Met Is a
Substrate of the Receptor Protein-tyrosine Phosphatase DEP-1*
§,
Cold Spring Harbor Laboratory, Cold Spring
Harbor, New York 11724 and the ¶ Molecular Oncology Group, McGill
University Hospital Center, Montreal, Quebec H3A 1A1, Canada
) has been implicated in the regulation of cell
growth, differentiation, and transformation, and most recently has been identified as a potential tumor suppressor gene mutated in colon, lung,
and breast cancers. We have generated constructs comprising the
cytoplasmic segment of DEP-1 fused to the maltose-binding protein to
identify potential substrates and thereby suggest a physiological
function for DEP-1. We have shown that the substrate-trapping mutant
form of DEP-1 interacted with a small subset of tyrosine-phosphorylated proteins from lysates of the human breast tumor cell lines MDA-MB-231, T-47D, and T-47D/Met and have identified the hepatocyte growth factor/scatter factor receptor Met, the adapter protein Gab1, and the junctional component p120 catenin as potential substrates. Following ligand stimulation, phosphorylation of specific tyrosyl residues in Met induces mitogenic, motogenic, and morphogenic responses. When co-expressed in 293 cells, the full-length
substrate-trapping mutant form of DEP-1 formed a stable complex with
the chimeric receptor colony stimulating factor 1 (CSF)-Met and
wild type DEP-1 dephosphorylated CSF-Met. Furthermore, we observed that
DEP-1 preferentially dephosphorylated a Gab1 binding site
(Tyr1349) and a COOH-terminal tyrosine implicated in
morphogenesis (Tyr1365), whereas tyrosine residues in the
activation loop of Met (Tyr1230, Tyr1234, and
Tyr1235) were not preferred targets of the PTP. The ability
of DEP-1 preferentially to dephosphorylate particular tyrosine residues that are required for Met-induced signaling suggests that DEP-1 may
function in controlling the specificity of signals induced by this PTK,
rather than as a simple "off-switch" to counteract PTK activity.
*
This work was supported in part by National Institutes of
Health Grant RO1-GM55989 (to N. K. T.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Cold Spring Harbor
Laboratory, Cold Spring Harbor, NY 11724. Tel.: 516-367-8846; Fax:
516-367-6812; E-mail: tonks@cshl.org.
This article has been cited by other articles:
![]() |
L. Karagyozov, R. Godfrey, S.-A. Bohmer, A. Petermann, S. Holters, A. Ostman, and F.-D. Bohmer The structure of the 5'-end of the protein-tyrosine phosphatase PTPRJ mRNA reveals a novel mechanism for translation attenuation Nucleic Acids Res., August 1, 2008; 36(13): 4443 - 4453. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shintani and M. Noda Protein Tyrosine Phosphatase Receptor Type Z Dephosphorylates TrkA Receptors and Attenuates NGF-dependent Neurite Outgrowth of PC12 Cells J. Biochem., August 1, 2008; 144(2): 259 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Arena, A. Pattarozzi, A. Massa, J.-P. Esteve, R. Iuliano, A. Fusco, C. Susini, and T. Florio An Intracellular Multi-Effector Complex Mediates Somatostatin Receptor 1 Activation of Phospho-Tyrosine Phosphatase {eta} Mol. Endocrinol., January 1, 2007; 21(1): 229 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takahashi, K. Takahashi, R. L. Mernaugh, N. Tsuboi, H. Liu, and T. O. Daniel A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis Blood, August 15, 2006; 108(4): 1234 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Lampugnani, F. Orsenigo, M. C. Gagliani, C. Tacchetti, and E. Dejana Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments J. Cell Biol., August 14, 2006; 174(4): 593 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iervolino, R. Iuliano, F. Trapasso, G. Viglietto, R. M. Melillo, F. Carlomagno, M. Santoro, and A. Fusco The Receptor-Type Protein Tyrosine Phosphatase J Antagonizes the Biochemical and Biological Effects of RET-Derived Oncoproteins. Cancer Res., June 15, 2006; 66(12): 6280 - 6287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wu, A. Katrekar, L. A. Honigberg, A. M. Smith, M. T. Conn, J. Tang, D. Jeffery, K. Mortara, J. Sampang, S. R. Williams, et al. Identification of Substrates of Human Protein-tyrosine Phosphatase PTPN22 J. Biol. Chem., April 21, 2006; 281(16): 11002 - 11010. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Machide, A. Hashigasako, K. Matsumoto, and T. Nakamura Contact Inhibition of Hepatocyte Growth Regulated by Functional Association of the c-Met/Hepatocyte Growth Factor Receptor and LAR Protein-tyrosine Phosphatase J. Biol. Chem., March 31, 2006; 281(13): 8765 - 8772. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Phillips-Mason, T. J. Gates, D. L. Major, D. B. Sacks, and S. M. Brady-Kalnay The Receptor Protein-tyrosine Phosphatase PTP{micro} Interacts with IQGAP1 J. Biol. Chem., February 24, 2006; 281(8): 4903 - 4910. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, L.-J. Tan, V. Grachtchouk, J. J. Voorhees, and G. J. Fisher Receptor-type Protein-tyrosine Phosphatase-{kappa} Regulates Epidermal Growth Factor Receptor Function J. Biol. Chem., December 30, 2005; 280(52): 42694 - 42700. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Berset, E. F. Hoier, and A. Hajnal The C. elegans homolog of the mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR signaling to regulate binary cell fate decisions Genes & Dev., June 1, 2005; 19(11): 1328 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Basar, Y. Shen, and K. Ireton Redundant Roles for Met Docking Site Tyrosines and the Gab1 Pleckstrin Homology Domain in InlB-Mediated Entry of Listeria monocytogenes Infect. Immun., April 1, 2005; 73(4): 2061 - 2074. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kappert, K. G. Peters, F. D. Bohmer, and A. Ostman Tyrosine phosphatases in vessel wall signaling Cardiovasc Res, February 15, 2005; 65(3): 587 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Motiwala, H. Kutay, K. Ghoshal, S. Bai, H. Seimiya, T. Tsuruo, S. Suster, C. Morrison, and S. T. Jacob Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer PNAS, September 21, 2004; 101(38): 13844 - 13849. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Massa, F. Barbieri, C. Aiello, S. Arena, A. Pattarozzi, P. Pirani, A. Corsaro, R. Iuliano, A. Fusco, G. Zona, et al. The Expression of the Phosphotyrosine Phosphatase DEP-1/PTP{eta} Dictates the Responsivity of Glioma Cells to Somatostatin Inhibition of Cell Proliferation J. Biol. Chem., July 9, 2004; 279(28): 29004 - 29012. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Ahn, J.-S. Kim, H.-K. Yu, H.-J. Lee, and Y. Yoon A Truncated Kringle Domain of Human Apolipoprotein(a) Inhibits the Activation of Extracellular Signal-regulated Kinase 1 and 2 through a Tyrosine Phosphatase-dependent Pathway J. Biol. Chem., May 21, 2004; 279(21): 21808 - 21814. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gensler, M. Buschbeck, and A. Ullrich Negative Regulation of HER2 Signaling by the PEST-type Protein-tyrosine Phosphatase BDP1 J. Biol. Chem., March 26, 2004; 279(13): 12110 - 12116. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Frank, C. Burkhardt, D. Imhof, J. Ringel, O. Zschornig, K. Wieligmann, M. Zacharias, and F.-D. Bohmer Effective Dephosphorylation of Src Substrates by SHP-1 J. Biol. Chem., March 19, 2004; 279(12): 11375 - 11383. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Mariner, M. A. Davis, and A. B. Reynolds EGFR signaling to p120-catenin through phosphorylation at Y228 J. Cell Sci., March 15, 2004; 117(8): 1339 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Persson, C. Savenhed, A. Bourdeau, M. L. Tremblay, B. Markova, F. D. Bohmer, F. G. Haj, B. G. Neel, A. Elson, C.-H. Heldin, et al. Site-Selective Regulation of Platelet-Derived Growth Factor {beta} Receptor Tyrosine Phosphorylation by T-Cell Protein Tyrosine Phosphatase Mol. Cell. Biol., March 1, 2004; 24(5): 2190 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. ANDERSEN, P. G. JANSEN, S. M. ECHWALD, O. H. MORTENSEN, T. FUKADA, R. DEL VECCHIO, N. K. TONKS, and N. P. H. MOLLER A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage FASEB J, January 1, 2004; 18(1): 8 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Lampugnani, A. Zanetti, M. Corada, T. Takahashi, G. Balconi, F. Breviario, F. Orsenigo, A. Cattelino, R. Kemler, T. O. Daniel, et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, {beta}-catenin, and the phosphatase DEP-1/CD148 J. Cell Biol., May 26, 2003; 161(4): 793 - 804. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |